A Novel Aminosaccharide Compound Blocks Immune Responses by Toll-like Receptors and Nucleotide-binding Domain, Leucine-rich Repeat Proteins
Open Access
- 1 February 2011
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 286 (7), 5727-5735
- https://doi.org/10.1074/jbc.m110.108001
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- The roles of TLRs, RLRs and NLRs in pathogen recognitionInternational Immunology, 2009
- Development of TLR inhibitors for the treatment of autoimmune diseasesImmunological Reviews, 2008
- Shared Principles in NF-κB SignalingCell, 2008
- NLR proteins: integral members of innate immunity and mediators of inflammatory diseasesJournal of Leukocyte Biology, 2007
- A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse modelJournal of Neuroinflammation, 2007
- Toll-like Receptor 7 and TLR9 Dictate Autoantibody Specificity and Have Opposing Inflammatory and Regulatory Roles in a Murine Model of LupusImmunity, 2006
- Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene DuplicationScience, 2006
- TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like ProteinScience, 2005
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999